Tale of Two Drugs (IMAGE) Cincinnati Children's Hospital Medical Center Caption While dupilumab's use has been extended to children under 12, benralizumab shows no benefit to patients with eosinophilic esophagitis (EoE). Credit Cincinnati Children's Usage Restrictions none License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.